INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-31.78B -26.5B -9.1B -7.47M -7.08M -7.08M -8.03M -8.81M -10.11M -10.67M -10.89M -8.03M -7.96M -6.98M -6.65M -10.56M -9.85M -9.36M
Depreciation & Amortization
752.73M 709.11M 622.28M 829.39K 619.4K 350.91K 200.89K 136.85K 193.45K 196.79K 192.29K 194.09K 163.4K 229.87K 166.08K 95.34K 57.73K 34.63K
Stock-Based Compensation
1.91B 1.29B 1.25B 1.6M 1.76M 1.09M 1.39M 1.63M 1.87M 2.01M 2.22M 2.81M 2.83M 2.88M 2.71M 2.13M 1.94M 1.6M
Other Working Capital
457.66K 148.71K n/a -346.2K -1.02M -621.23K -388.67K 19.29K 604.93K 699.54K 425.95K -2.96M -3.06M -3.47M -3.67M -888.5K -974.81K -961.7K
Other Non-Cash Items
20.88B 17.98B 4.25B 1.81M 1.91M 1.81M 1.22M 994.05K 704.36K 628.84K 448.85K 403.14K 414.5K 399.27K 1.19M 2.96M 3.3M 3.45M
Deferred Income Tax
n/a n/a n/a -6.32K 1.84K -1.95K -1.95K 5.18K -2.98K 810.00 810.00 214.05K 326.04K 168.42K 168.42K -45.63K -157.62K 0.04
Change in Working Capital
524.44K -285.11K n/a 394.24K -648.94K 204.69K 471.7K 1M 1.9M 2.11M 1.37M -2.76M -2.9M -3.07M -3.61M -924.76K -961.36K -1.37M
Operating Cash Flow
-8.24B -6.52B -2.97B -3.07M -3.68M -3.87M -4.76M -5.04M -5.45M -5.67M -6.6M -7.11M -7.07M -6.37M -6.03M -6.34M -5.67M -5.65M
Capital Expenditures
104.83K 49.7K n/a -75K -288.05K -494.42K -444.72K -369.59K -264.38K -6.16K -12.73K -427.82K -1.17M -1.18M -1.2M -813.71K -94.58K -92.78K
Cash Acquisitions
n/a -25.59K n/a 32.7K -2.04M -2.02M -2.05M -2.15M 1.00 -1.61K -68.49K -1.52M -895.8K -1.77M -1.7M -318.29K -945.41K -65.41K
Purchase of Investments
n/a n/a n/a 8.45K 8.45K 8.45K n/a 1.00 1.00 -1.61K -68.49K -1.52M -1.78M -1.77M -1.7M -252.88K n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 2.49M 2.49M 2.49M 2.49M -16.9K -16.9K -16.9K -16.9K n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
333.72M 349.22M 363.85M -31.72M -2.48M -2.53M -2.49M 16.89K 16.47K 14.25K -70.43K 864.22K 1.29M 693.98K 490.21K -453.12K -912.91K -317.51K
Investing Cash Flow
333.83M 349.27M 363.89M -29.21M -2.25M -2.51M -2.49M -2.52M -264.38K -7.77K -81.22K -1.01M -1.32M -1.93M -2.15M -1.33M -1.07M -471.1K
Debt Repayment
116.18K -27.37K n/a -225.75K 1.19M 1.15M 1.66M 1.81M 353.85K 544K n/a n/a n/a n/a n/a 255K 609.39K 2.92M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-861.13M -555.88M -250.63M -250.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
8.91B 7.17B 3.2B 252.06M 1.42M 523.05K 2.73M 3.51M 3.51M 3.51M 800K 3.4M 3.4M 3.4M 3.77M 11.22M 11.27M 11.27M
Financial Cash Flow
8.22B 6.78B 3.12B 2.48M 6.76M 4.66M 7.39M 8.33M 3.86M 4.03M 1.09M 3.69M 3.72M 3.72M 3.77M 11.48M 11.88M 14.19M
Net Cash Flow
548.24M 839.93M 741.16M -583.95K 830.45K -1.71M 142.29K 769.85K -1.85M -1.65M -5.59M -4.43M -4.68M -4.58M -4.41M 3.8M 5.14M 8.07M
Free Cash Flow
-10.59B -8.87B -5.33B -2.36B -3.97M -4.36M -5.2M -5.41M -5.71M -5.68M -6.62M -7.54M -8.24M -7.55M -7.23M -7.15M -5.76M -5.74M